2023-07-20 22:06:18
New Method Developed at Paul Scherrer Institute to Improve Breast Cancer Detection
In an effort to improve the detection of breast cancer, researchers at the Paul Scherrer Institute (PSI) in Villigen/Würenlingen AG and ETH Zurich have developed a new method that promises earlier and more reliable diagnosis. Clinical trials are set to take place at the University Hospital Zurich (USZ) and the Cantonal Hospital Baden (KSB) starting from 2024.
Breast cancer screening has long been a crucial tool in the fight against the disease. However, the new method developed by the team at PSI and ETH Zurich aims to further improve the effectiveness of early tumor detection while minimizing discomfort for patients.
The researchers believe that their method could significantly increase the chances of survival for women affected by breast cancer. By detecting tumors at an earlier stage, the opportunity for timely intervention and treatment is enhanced. Marco Stampanoni, a researcher from PSI and ETH, describes the development as an important step forward in the fight against breast cancer.
According to data from 2020, breast cancer is the most commonly diagnosed cancer globally, with over two million cases reported. Among women, it accounts for 24.5 percent of cancer cases and 15.5 percent of cancer-related deaths. Mammography screening programs are widely implemented in many industrialized countries as a preventive measure. However, the new method developed at PSI aims to improve upon the existing screening techniques.
The team led by Marco Stampanoni published several images in the specialist journal Optica to demonstrate the advantages of their computed tomography approach. The goal is to reduce the radiation dose by two to three times while maintaining the same resolution or increasing it by 18 to 45 percent compared to conventional X-rays.
Clinical trials at the University Hospital Zurich and the Cantonal Hospital Baden will provide further insights into the efficacy of the new method. Women, as well as doctors, are hopeful for an improved breast cancer screening process that can lead to earlier detection and better outcomes for patients. With the potential for earlier diagnosis and improved therapy, the new method developed at PSI holds promise for making significant strides in the fight against breast cancer.
The results of the clinical trials are eagerly anticipated as they have the potential to shape the future of breast cancer screening and provide hope for millions of women worldwide.]
#detection #breast #cancer #Aargau